NASD · Basic Materials · Agricultural Inputs · Israel
Nexentis Technologies Inc is a micro cap company (market value under $300 million) in the Agricultural Inputs industry.
Nexentis Technologies Inc. operates subsidiaries and joint ventures in biotechnology and renewable energy sectors. MitoCareX discovers and develops drug treatments for cancer and inflammatory metabolic disorders by targeting mitochondrial transport proteins. Solterra identifies and develops solar photovoltaic projects for sale across Italy, Poland, and Germany.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Nexentis Technologies Inc stock.
Overvalued: intrinsic value $0.46 per share, market price $0.59, margin of safety -29.2% (as of 2026-10-30).
Its liquidation floor, current assets minus every liability, values the shares at $0.46; the price of $0.59 is 29% above that value.
Leak Score: 38/100 on 8 of 12 signals (On Watch).
All 13 Agricultural Inputs stocks
1 more in this industry show a wider margin of safety.
NXTS is overvalued (as of the 2026-10-30 close). Its liquidation floor, current assets minus every liability, values the shares at $0.46; the price of $0.59 is 29% above that value.
$0.46 per share (as of the 2026-10-30 close), against a market price of $0.59. That is a margin of safety of -29.2%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
38 out of 100, which we rate "On Watch", on 8 of 12 value investing signals.